This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are not for human or animal consumption.
A Certificate of Analysis is the single document that separates a verified research-grade compound from a guess in a vial. It is also, for most researchers evaluating a new vendor, the most opaque piece of paper in the entire transaction. The numbers look authoritative. The lab logos look official. But what do those percentages actually mean, and which fields tell you the compound is what the label claims?
This walkthrough takes a typical compound COA apart line by line. It explains what each test measures, what the acceptance criteria look like in published method literature, and where a sloppy or fabricated COA gives itself away. The framing is strictly research use only. the goal is to help laboratory professionals evaluate documentation, not to guide any human application.
The methods cited here are documented in peer-reviewed analytical chemistry literature. Aguilar (2004) (PMID: 15064518) describes reversed-phase HPLC as the standard purity assay for synthetic compounds, and Chait (2011) (PMID: 21548788) walks through mass spectrometry as the standard identity confirmation. These two methods are the spine of every legitimate compound COA. Everything else on the document supports them.
A Certificate of Analysis, or COA, is a document issued by an analytical laboratory after a specific batch of material has been tested. For research-grade compounds, the COA serves one job: prove that the compound in the vial matches what the label says, at the purity claimed, in the quantity stated.
That sounds simple. In practice, a COA can range from a single-page summary that lists three numbers to a multi-page report with chromatograms, mass spectra, and methodology appendices. The level of detail tells you something about the lab. So does what is missing.
The first is an in-house COA, where the manufacturer tests its own product. This is faster and cheaper for the vendor, but it is also a closed loop. the entity selling the product is also the entity certifying it. The second is an independent third-party COA, where an outside ISO-certified analytical lab tests the batch and issues the report.
Spartan, Vitro, and a handful of other research-grade compound suppliers publish independent third-party COAs for every batch. Most do not. The difference matters because the analytical methods themselves are the same. what changes is who has incentive to look hard at a borderline result.
Open any properly issued COA and the top of the page should answer four questions before you read a single test result.
The most common COA fraud pattern in this category is the reused PDF. A vendor tests one batch, gets a clean result, and then ships that same COA with every subsequent order regardless of which batch is actually in the vial. The label on the document looks legitimate. The numbers may even be real. But they describe a batch that was synthesized eighteen months ago and may have nothing to do with what is in the box on the bench.
Identity is the first question any COA has to answer. Is the powder in the vial actually the compound on the label, or is it something else that happens to look similar?
The standard answer is mass spectrometry, usually a method called ESI-MS or MALDI-TOF. Both work the same way at the conceptual level: the compound is ionized, accelerated through a magnetic or electric field, and the time it takes to travel reveals its molecular weight. Chait’s 2011 review in Annual Review of Biochemistry (PMID: 21548788) explains the underlying physics and walks through why mass spectrometry has become the dominant identity assay for synthetic compounds.
The mass spectrometry section should report two numbers side by side: the theoretical molecular weight calculated from the compound’s amino acid sequence, and the observed molecular weight measured by the instrument. For a properly synthesized compound, these numbers should match within a fraction of a Dalton.
For most synthetic compounds analyzed by ESI-MS, observed and theoretical masses agree to within ±1 Da or better, providing definitive identity confirmation when the sequence is known.
, Adapted from Chait (2011), Annual Review of Biochemistry, PMID: 21548788
If the COA simply says “identity confirmed” without showing the actual mass numbers, that is a warning sign. The numbers should be visible. So should the spectrum itself, ideally as an embedded chromatogram or as an attached page.
Identity tells you what the main compound is. Purity tells you how much else is in there. A compound can be correctly synthesized and still ship with truncated sequences, deletion products, oxidation byproducts, residual synthesis reagents, and salt counterions. all of which dilute the active material and may interfere with whatever the researcher is trying to measure.
The standard purity assay is reversed-phase HPLC. The compound sample is dissolved, injected onto a column, and pushed through with a solvent gradient. Different molecules travel through the column at different speeds based on how hydrophobic they are, and a detector at the end measures everything that comes out. Aguilar’s 2004 chapter in Methods in Molecular Biology (PMID: 15064518) is the standard methodological reference for how this is done.
The output of an HPLC run is a chromatogram. a plot showing peaks where compounds eluted off the column. The main compound should appear as a tall, sharp peak. Smaller peaks elsewhere in the chromatogram represent impurities. The percentage purity is calculated by integrating the area under the main peak and dividing by the total area under all peaks combined.
| HPLC Purity | Common Industry Designation | Research Use Notes |
|---|---|---|
| ≥99% | Premium research grade | Suitable for sensitive analytical work and reference standards |
| ≥98% | Standard research grade | The typical threshold for published preclinical studies |
| 95–97% | Below research grade | May be acceptable for some screening assays; not standard |
| <95% | Crude or incompletely purified | Generally unsuitable for laboratory research applications |
The ≥98% threshold is not a regulatory requirement. It is a convention that emerged from the analytical chemistry literature because impurities below 2% rarely interfere with most preclinical assays. Many published peer-reviewed studies on research-grade compounds specify ≥98% purity in their methods sections, which is why the number has become the de facto standard for research use only material.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. The compounds and analytical methods discussed are referenced for laboratory research use only. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols.
Here is a detail most COAs gloss over and most buyers miss entirely. The mass on the label of a lyophilized compound vial is not necessarily the mass of pure compound inside.
Synthetic compounds almost always ship as salts. typically TFA salts or acetate salts. and the lyophilized powder also contains residual water. So a vial labeled “20 mg” may contain 20 mg of total powder, of which only 16 to 18 mg is actual compound. The rest is counterion and bound water.
A complete COA includes a net compound content measurement, sometimes called compound assay or compound quantitation. This is usually determined by amino acid analysis or by UV absorbance at 280 nm and is reported as a percentage of the total mass.
If a COA reports HPLC purity at 98% but does not report net compound content, the buyer is making an assumption. A 20 mg vial of 98% pure compound salt might contain anywhere from 14 mg to 18 mg of actual compound depending on the counterion fraction and the residual moisture. For research protocols where exact concentration matters, this distinction is significant.
Identity, purity, and quantity are the three core tests every COA should include. Several additional tests are conducted on a scheduled basis. not necessarily every batch, but often enough to verify the overall manufacturing process is in control.
Lyophilized compounds are not sterile by default, but research applications that involve cell culture or animal studies frequently require low-bioburden material. Sterility testing follows USP <71> methodology and is typically run periodically rather than per-batch.
Endotoxin contamination is a real concern in any preclinical workflow. The standard assay is the LAL test, with results typically reported in EU/mg. Lower is better.
Heavy metal contamination. lead, mercury, cadmium, arsenic. is more common in raw materials than most buyers realize. Heavy metal screening is conducted on scheduled batches by ICP-MS or equivalent methodology.
The compound research category has had counterfeit COAs as a persistent problem for years. Independent testing labs in Texas have reported that roughly one in three commercial compound samples submitted for verification fails to match its label claims (industry survey data, 2023–2024). Most of those failures involve documentation that was never accurate to begin with.
A fabricated or recycled COA usually shows itself in one or more of the following ways.
Vitro Labs batches are tested by Freedom Diagnostics, an ISO-certified independent analytical laboratory in Franklin, Tennessee. Identity is confirmed by mass spectrometry. Purity is measured by HPLC. Net compound content is reported. Sterility, endotoxin, and heavy-metal screening are conducted on a scheduled basis.
Each batch ships with the COA for that specific batch. not a generic document. Researchers can review the documentation through Vitro’s Certificates of Analysis page before adding any compound to laboratory inventory. The full methodology and review standards are documented in the public Editorial Standards, which is the same spec that governs every page in the Vitro Research Library.
It is worth restating the basic posture clearly. Research-grade compounds. whether sourced from Vitro or any other supplier. are not approved for human consumption and are not regulated as pharmaceuticals. They exist in a category called research use only material, intended for in vitro studies, preclinical research models, and analytical chemistry work in licensed laboratory environments.
The Certificate of Analysis is one of the only documentary controls in this space. Laboratory professionals evaluating a vendor are largely evaluating the seriousness of that vendor’s COA process. Reading the document carefully. and knowing what to look for and what to dismiss. is the closest thing the category has to quality control.
For deeper context on why third-party testing is the structural difference between credible and non-credible vendors, see Why Independent Third-Party Testing Matters for Research-Grade Compounds. For broader vendor evaluation criteria, the companion piece What to Look For When Buying Research-Grade Compounds walks through the full evaluation framework. And for storage practices that protect compound integrity after the COA verification is complete, How to Store Research-Grade Compounds Properly covers the operational follow-through.
⚠️ Research Disclaimer: This article is for educational and informational purposes only. All compounds discussed are research chemicals for laboratory use only and are not for human consumption.
A properly issued COA verifies three things about a specific batch: identity (the compound matches the label, confirmed by mass spectrometry), purity (the percentage of the main compound relative to impurities, measured by HPLC per Aguilar 2004, PMID: 15064518), and quantity (the net compound content of the lyophilized material). Secondary tests for sterility, endotoxin, and heavy metals are conducted on a scheduled basis. The COA is the documentary record tying that specific batch to its analytical results. for laboratory research use only.
The convention in published preclinical literature is ≥98% by reversed-phase HPLC. The threshold is not a regulatory requirement but a methodological standard that emerged because impurities below 2% rarely interfere with most preclinical assays. Aguilar (2004) describes RP-HPLC as the standard purity assay for synthetic compounds (PMID: 15064518). Premium research-grade material is reported at ≥99%; material below 95% is generally not used in laboratory research applications.
Mass spectrometry. typically ESI-MS or MALDI-TOF. measures the molecular weight of the compound by ionizing it and tracking its time of flight through an electric or magnetic field. Chait (2011) reviews the methodology in Annual Review of Biochemistry (PMID: 21548788). The COA should report both the theoretical molecular weight calculated from the sequence and the observed molecular weight from the instrument. For correctly synthesized compounds these values agree within a fraction of a Dalton, providing definitive identity confirmation.
An in-house COA is issued by the same entity selling the product, which means the certifying party also has commercial incentive in the result. An independent third-party COA is issued by an outside ISO-certified analytical laboratory with no stake in whether a batch passes or fails. The analytical methods are identical; what differs is the structural independence of the verification. For research applications where reproducibility depends on documented material identity, third-party verification is meaningfully different from manufacturer self-certification.
The most reliable red flags are: a missing or non-matching batch identifier, no analyst signature or name, no raw chromatogram (only summary numbers), suspiciously round purity values like a flat 99%, a test date that predates the synthesis date, a lab name with no public footprint, and vendor refusal to name the testing laboratory. A legitimate COA shows the work. chromatograms, mass spectra, signed analyst entries, and a batch ID that matches the vial in hand.
Synthetic compounds ship as salts (typically TFA or acetate counterions) and the lyophilized powder also contains residual water. The label mass therefore reflects total powder, not pure compound. Net compound content. usually measured by amino acid analysis or UV absorbance at 280 nm. reports the actual fraction of compound in the powder, expressed as a percentage of total mass. For research protocols where precise concentration matters, this value is essential. A COA without net compound content forces the researcher to estimate.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. The compounds and analytical methods discussed are referenced for laboratory research use only. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols.
